Update on the diagnosis and treatment of pulmonary tuberculosis.
Rev Clin Esp (Barc)
; 216(2): 76-84, 2016 Mar.
Article
en En, Es
| MEDLINE
| ID: mdl-26494306
Tuberculosis (TB) remains the most important human infectious disease. Currently, the TB diagnosis is still based on the clinical presentation, radiographic findings and microbiological results; all of which have sensitivity or specificity issues. For that reason, the immediate future involves rapid molecular microbiological techniques, in particular GeneXpert (which is more sensitive than bacilloscopy and is able to detect rifampicin resistance) and GenoType. The current six-month treatment for TB has remained unchanged for decades. Attempts to shorten this treatment have failed. In recent years, new drugs have been reported that could contribute to TB treatment in the near future, and are already being used in multi-drug-resistance TB.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Tipo de estudio:
Diagnostic_studies
Idioma:
En
/
Es
Revista:
Rev Clin Esp (Barc)
Año:
2016
Tipo del documento:
Article
Pais de publicación:
España